Bellevue Life Sciences Acquisition Corp. News

10-Q: Q3 2024 Earnings Report

Nov 15 06:11

SC 13G: Statement of acquisition of beneficial ownership by individuals-RIVERNORTH CAPITAL MANAGEMENT, LLC(6.07%)

Nov 15 05:53

8-K: Current report

Nov 13 05:58

S-4/A: Registration of securities issued in business combination transactions (Amendment)

Nov 9 11:19

ARS: Annual Report to Security Holders

Oct 28 21:04

DEF 14A: Definitive information statements

Oct 28 21:04

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Oct 28 20:39

8-K: Current report

Oct 28 20:34

8-K: Current report

Oct 23 04:24

PRE 14A: Preliminary proxy statements relating to merger or acquisition

Oct 19 05:34

8-K: Current report

Oct 16 04:25

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Oct 11 04:40

8-K: Current report

Oct 11 04:36

8-K: Current report

Oct 11 04:35

8-K: Current report

Sep 25 04:26

8-K: Current report

Sep 17 04:19

8-K: Current report

Aug 23 04:25

10-Q: Q2 2024 Earnings Report

Aug 20 04:23

8-K: Current report

Aug 17 04:24

NT 10-Q: Notice under Rule 12b25 of inability to timely file all or part of a form 10-Q or 10-QSB

Aug 16 04:34